Coronary disease: Acute myocardial infarction: Primary angioplasty

Heart

Volumn 85, Issue 6, 2001, Pages 705-709

  Zijlstra, F ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; NITRIC ACID DERIVATIVE;

ACUTE HEART INFARCTION; ANGIOCARDIOGRAPHY; CORONARY STENT; FIBRINOLYTIC THERAPY; HEART MUSCLE REPERFUSION; HUMAN; INTRACORONARY INFUSION; PATHOPHYSIOLOGY; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT INDICATION; TREATMENT OUTCOME; HEART INFARCTION; METHODOLOGY; RISK FACTOR; STENT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; HUMANS; MYOCARDIAL INFARCTION; PATIENT SELECTION; RISK FACTORS; STENTS; THROMBOLYTIC THERAPY;

EID: 0034762542     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.85.6.705     Document Type: Review

References (20)

1. Acute myocardial infarction: Pre-hospital and in-hospital management
2. Percutaneous transluminal coronary angioplasty with and without thrombolytic therapy for treatment of acute myocardial infarction
3. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction
4. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction
5. Characteristics, management, and outcome of patients with acute myocardial infarction treated with bypass surgery
6. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative overview
7. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction
8. Projected cost-effectiveness of primary angioplasty for acute myocardial infarction
9. The volume of primary angioplasty procedures and survival after myocardial infarction
10. Coronary angioplasty with or without stent implantation for acute myocardial infarction
11. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory: The PRAGUE study
12. Lessons from the pooled outcome of the Pami, Zwolle and Mayo Clinic randomized trials of primary angioplasty versus thrombolytic therapy of acute myocardial infarction
13. Myocardial contrast echocardiography in acute myocardial infarction: Pathophysiological background and clinical applications
14. Extent of early ST segment elevation resolution: A simple but strong predictor of outcome in patients with acute myocardial infarction
15. Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction
16. Long-term benefit of primary angioplasty compared to thrombolytic therapy for acute myocardial infarction
17. High dose heparin as pretreatment for primary angioplasty in acute myocardial infarction: The heparin in early patency (HEAP) randomized trial
18. A randomized trial comparing primary angioplasty with a strategy of short-acting thrombolysis and immediate planned rescue angioplasty in acute myocardial infarction: The PACT trial
19. Randomised, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction
20. Abciximab in the treatment of acute myocardial infarction eligible for primary percutaneous transluminal coronary angioplasty. Results of the glycoprotein receptor antagonist patency evaluation (Grape) pilot study